President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
All content for The Commercial Awareness Compass by AllAboutLaw is the property of AllAboutLaw and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
Reputation on the ropes: when brands face public backlash | Commercial Awareness Compass #40
The Commercial Awareness Compass by AllAboutLaw
33 minutes
3 months ago
Reputation on the ropes: when brands face public backlash | Commercial Awareness Compass #40
In an era where social media can propel a complaint to millions within hours, brand reputation has never been more fragile — or more powerful. One post, one misjudged partnership, one policy misstep: that’s all it takes to send years of brand trust into spiralling. But with the right commercial and legal strategies, damage doesn’t have to mean disaster. In this episode we explore how businesses build trust, manage crises, and rebuild when things go wrong, what effective brand protection real...
The Commercial Awareness Compass by AllAboutLaw
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...